Skip to main content

FDA issues warning letters to 2 CBD brands marketing violations

Honest Globe and Biolyte Labs received letters for their marketing practices, as well as for substandard manufacturing practices, according to the Food and Drug Administration.
salazar

The Food and Drug Administration has sent warning letters to two companies for selling products with CBD in ways that violate the federal Food, Drug and Cosmetic Act. Honest Globe and Biolyte Labs received letters because CBD cannot be legally marketed as an inactive ingredient in OTC drug products that haven’t been reviewed and approved by the FDA, as well as substandard manufacturing practices. 

"The FDA continues to alert the public to potential safety and efficacy concerns with unapproved CBD products sold online and in stores across the country," said FDA principal deputy commissioner Dr. Amy Abernethy. "It's important that consumers understand that the FDA has only approved one drug containing CBD as an ingredient. These other, unapproved, CBD products may have dangerous health impacts and side effects. We remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD's safety. Meanwhile, we will continue to monitor and take action, as needed, against companies that unlawfully market their products — prioritizing those that pose a risk to public health."  

The FDA noted that the products covered by the warning letters had not gone through the FDA’s drug approval process and are considered unapproved new drugs. The agency also has not evaluated whether the products are effective for uses that manufacturers claim, what an appropriate dose might be, how they might interact with FDA-approved drugs or any potential side effects or safety concerns. 

The agency requested written responses from the companies within 15 working days, addressing how they will address the violations or providing reasoning and supporting information as to why they believe the products don’t violate the law. 
 

Most Popular Content

P2PI Events

Mark your calendar for Path to Purchase Institute events in 2026 and 2027. Members receive discounts on registration.
logo

Inside Danone's Blueprint for Omnichannel Success

Danone is implementing a shopper-centric strategy to navigate a complex, nonlinear path to purchase by integrating digital influence with in-store conversion.
Danone

P2PI Names 40 Under 40 Class of 2026

The fifth annual awards program spotlights the next generation of leaders in commerce marketing.
40 under 40 2026 winners

2026 Women of Excellence Profiles: Industry Impact

Read about the Industry Impact winners from The Hershey Co., Ahold Delhaize USA, Mars Snacking, DoorDash, Blue Chip, Epsilon, Pentaleap, Flywheel, Havas Media Network North America and Circana.
2026

Creating Routines and Habits Around Your Brand: Getting More Out of the Programming You Already Plan

How brand and shopper teams can keep the shoppers their programs already reach, learn from them and make every promotion start ahead of the last.
Goxcm image
X
This ad will auto-close in 10 seconds